The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CHINA BIOLOGIC PRODS INC | COM | 16938C106 | 574 | 5,731 | SH | DFND | 1 | 5,731 | 0 | 0 | |
| CREDICORP LTD | COM | G2519Y108 | 555 | 3,398 | SH | DFND | 1 | 3,398 | 0 | 0 | |
| ISHARES TR | MSCI INDIA ETF | 46429B598 | 2,104 | 66,819 | SH | DFND | 1 | 66,819 | 0 | 0 | |